合計 50 件の最近のインサイダー取引記録が記録されています AVROBIO, Inc. (AVRO), 内訳は 39 件の買い および 9 件の売り. インサイダー買い総額は $2.93M インサイダー売り総額は $303.13K.
最近活動のある主要インサイダーには Leonard Braden Michael, Avruch Steven, Ostrowski Erik. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — AVRO
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-05-14 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
296,882 |
$1.30 |
$385.95K |
4,768,262 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
不明 |
- |
- |
- |
4,471,380 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
情報に基づく買い |
253,700 |
$1.24 |
$313.32K |
4,255,327 |
| 2024-05-13 |
Leonard Braden Michael |
10 Percent Owner |
処分 |
- |
- |
- |
400,000 |
| 2024-02-05 |
Avruch Steven |
Chief Legal Officer |
RSU 源泉徴収 |
10,812 |
$1.20 |
$13K |
22,022 |
| 2024-02-05 |
Ostrowski Erik |
Interim CEO, President and CFO |
RSU 源泉徴収 |
13,099 |
$1.20 |
$15.74K |
29,285 |
| 2024-02-05 |
Ridha Essra |
Chief Medical Officer |
RSU 源泉徴収 |
16,953 |
$1.20 |
$20.35K |
15,881 |
| 2024-02-05 |
Golipour Azadeh |
Chief Technology Officer |
RSU 源泉徴収 |
12,232 |
$1.20 |
$14.7K |
55,872 |
| 2024-02-01 |
Avruch Steven |
Chief Legal Officer |
オプション行使 |
32,834 |
- |
- |
32,834 |
| 2024-02-01 |
Ostrowski Erik |
Interim CEO, President and CFO |
オプション行使 |
40,084 |
- |
- |
42,384 |
| 2024-02-01 |
Ridha Essra |
Chief Medical Officer |
オプション行使 |
32,834 |
- |
- |
32,834 |
| 2024-02-01 |
Golipour Azadeh |
Chief Technology Officer |
オプション行使 |
37,334 |
- |
- |
68,104 |
| 2023-07-01 |
Ostrowski Erik |
Interim CEO, President and CFO |
RSU 付与（制限付株式） |
70,000 |
- |
- |
70,000 |
| 2023-06-12 |
Golipour Azadeh |
Chief Technology Officer |
RSU 源泉徴収 |
111 |
$1.21 |
$133.76 |
30,770 |
| 2023-06-06 |
Donenberg Phillip B. |
Director |
RSU 付与（制限付株式） |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Clark Ian T |
Director |
RSU 付与（制限付株式） |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Booth Bruce |
Director |
RSU 付与（制限付株式） |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Farfel Gail M |
Director |
RSU 付与（制限付株式） |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Vickers Philip J. |
Director |
RSU 付与（制限付株式） |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Jenkins Annalisa |
Director |
RSU 付与（制限付株式） |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-06-06 |
Paige Christopher |
Director |
RSU 付与（制限付株式） |
17,643 |
$1.09 |
$19.23K |
17,643 |
| 2023-02-08 |
Petersen Deanna M |
Chief Business Officer |
RSU 付与（制限付株式） |
86,667 |
- |
- |
86,667 |
| 2023-02-08 |
Mackay Geoffrey |
President & CEO |
RSU 付与（制限付株式） |
300,667 |
- |
- |
300,667 |
| 2023-02-08 |
Avruch Steven |
Chief Legal Officer |
RSU 付与（制限付株式） |
131,333 |
- |
- |
131,333 |
| 2023-02-08 |
Ostrowski Erik |
Chief Financial Officer |
RSU 付与（制限付株式） |
160,333 |
- |
- |
160,333 |
| 2023-02-08 |
Ridha Essra |
Chief Medical Officer |
RSU 付与（制限付株式） |
131,333 |
- |
- |
131,333 |
| 2023-02-08 |
Golipour Azadeh |
Chief Technology Officer |
RSU 付与（制限付株式） |
149,333 |
- |
- |
149,333 |
| 2023-01-24 |
Mackay Geoffrey |
President & CEO |
オプション行使（売却） |
45,999 |
- |
- |
- |
| 2022-12-28 |
Mackay Geoffrey |
President & CEO |
贈与（送付） |
245,123 |
- |
- |
142,013 |
| 2022-12-23 |
Mackay Geoffrey |
President & CEO |
オプション行使（売却） |
142,013 |
- |
- |
- |
| 2022-12-08 |
Petersen Deanna M |
Chief Business Officer |
RSU 付与（制限付株式） |
111,500 |
- |
- |
111,500 |
| 2022-12-08 |
Mackay Geoffrey |
President & CEO |
RSU 付与（制限付株式） |
388,000 |
- |
- |
388,000 |
| 2022-12-08 |
Avruch Steven |
Chief Legal Officer |
RSU 付与（制限付株式） |
169,500 |
- |
- |
169,500 |
| 2022-12-08 |
Ostrowski Erik |
Chief Financial Officer |
RSU 付与（制限付株式） |
221,000 |
- |
- |
221,000 |
| 2022-12-08 |
Ridha Essra |
Chief Medical Officer |
RSU 付与（制限付株式） |
183,000 |
- |
- |
183,000 |
| 2022-12-08 |
Golipour Azadeh |
Chief Technology Officer |
RSU 付与（制限付株式） |
165,000 |
- |
- |
165,000 |
| 2022-06-08 |
Donenberg Phillip B. |
Director |
RSU 付与（制限付株式） |
17,478 |
- |
- |
17,478 |
| 2022-06-08 |
Clark Ian T |
Director |
RSU 付与（制限付株式） |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Booth Bruce |
Director |
RSU 付与（制限付株式） |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Farfel Gail M |
Director |
RSU 付与（制限付株式） |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Vickers Philip J. |
Director |
RSU 付与（制限付株式） |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Jenkins Annalisa |
Director |
RSU 付与（制限付株式） |
17,478 |
- |
- |
17,478 |
| 2022-06-08 |
Paige Christopher |
Director |
RSU 付与（制限付株式） |
17,478 |
$1.06 |
$18.53K |
17,478 |
| 2022-06-08 |
Golipour Azadeh |
Chief Technology Officer |
処分 |
130,000 |
$1.84 |
$239.2K |
- |
| 2022-02-02 |
Petersen Deanna M |
Chief Business Officer |
RSU 付与（制限付株式） |
80,000 |
$1.84 |
$147.2K |
80,000 |
| 2022-02-02 |
Mackay Geoffrey |
President & CEO |
RSU 付与（制限付株式） |
328,500 |
$1.84 |
$604.44K |
328,500 |
| 2022-02-02 |
Avruch Steven |
Chief Legal Officer |
RSU 付与（制限付株式） |
90,000 |
$1.84 |
$165.6K |
90,000 |
| 2022-02-02 |
Ostrowski Erik |
Chief Financial Officer |
RSU 付与（制限付株式） |
145,000 |
$1.84 |
$266.8K |
145,000 |
| 2022-02-02 |
Ridha Essra |
Chief Medical Officer |
RSU 付与（制限付株式） |
75,000 |
$1.84 |
$138K |
75,000 |
| 2021-11-01 |
Ridha Essra |
Chief Medical Officer |
RSU 付与（制限付株式） |
120,000 |
$5.67 |
$680.4K |
120,000 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
